Related Experiment Videos
Valve repair for rheumatic mitral disease
I Mavioglu1, O V Dogan, M Ozeren
1Cardiovascular Surgery Department, Ankara Teaching Hospital, Social Security Organization, Turkey.
The Journal of Heart Valve Disease
|October 18, 2001
Summary
Mitral valve repair is effective for rheumatic heart disease, showing low mortality and reoperation rates. This study confirms repair is a suitable option for young patients with rheumatic mitral valve disease.
Area of Science:
- Cardiovascular Surgery
- Rheumatology
- Cardiac Valve Disease
Background:
- Mitral valve repair is standard for degenerative mitral disease.
- Repair outcomes in rheumatic disease are encouraging.
- Suitability of repair for rheumatic mitral valve disease in young patients requires evaluation.
Purpose of the Study:
- To evaluate outcomes of mitral valve repair in young patients with rheumatic mitral disease.
- To assess the suitability of mitral valve repair for rheumatic mitral valve disease.
Main Methods:
- A total of 319 patients (mean age 31.3 years) underwent mitral valve repair for rheumatic mitral disease.
- Follow-up averaged 51.9 months (88.7% complete).
- Preoperative assessment included NYHA class and valve pathology (stenosis, insufficiency).
Main Results:
- Preoperatively, 47.6% of patients were in NYHA classes III/IV; 87.5% had mitral stenosis.
- Intraoperative mortality was 0.9%, reoperation rate was 6.7%, with 0% reoperation mortality.
- Postoperatively, 98% of patients improved to NYHA classes I/II, with a 2.1% cardiac-related late death rate.
Conclusions:
- Mitral valve repair in rheumatic disease demonstrates low mortality, complication, and reoperation rates.
- Good cardiac function and late survival are achievable with mitral valve repair.
- Rheumatic mitral valves are suitable for repair, similar to degenerative mitral disease.